Canada markets open in 1 hour 57 minutes

  • S&P/TSX

    19,556.15
    -244.46 (-1.23%)
     

  • S&P 500

    4,273.53
    -63.91 (-1.47%)
     

  • DOW

    33,618.88
    -388.00 (-1.14%)
     

  • CAD/USD

    0.7392
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    91.87
    +1.48 (+1.64%)
     

  • Bitcoin CAD

    35,944.89
    +464.41 (+1.31%)
     

  • CMC Crypto 200

    569.91
    +6.10 (+1.08%)
     

  • GOLD FUTURES

    1,910.50
    -9.30 (-0.48%)
     

  • RUSSELL 2000

    1,761.61
    -22.63 (-1.27%)
     

  • 10-Yr Bond

    4.5580
    0.0000 (0.00%)
     

  • NASDAQ futures

    14,772.75
    +57.75 (+0.39%)
     

  • VOLATILITY

    18.12
    -0.82 (-4.33%)
     

  • FTSE

    7,611.99
    -13.73 (-0.18%)
     

  • NIKKEI 225

    32,371.90
    +56.85 (+0.18%)
     

  • CAD/EUR

    0.7008
    +0.0014 (+0.20%)
     

Celldex Therapeutics to Present at H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Celldex Therapeutics, Inc.
·1 min read
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.

HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 30th at 11:30 am ET. A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com